Alumni raised $1.45B in 2022 - Download Free Report Now

Juventas Therapeutics (fka AcelleRX Therapeutics)

Regenerative stem cell therapy to treat heart failure (HF), acute myocardial infarction (MI), angina, peripheral artery disease (PAD), and hard-to-hea....

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Juventas Therapeutics (fka AcelleRX Therapeutics) plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About Juventas Therapeutics (fka AcelleRX Therapeutics)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More

Companies We Work With